XML 73 R48.htm IDEA: XBRL DOCUMENT v3.25.0.1
Shareholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Common Stock Outstanding Roll Forward
a) The Company has 50,000,000 shares of no par value common stock authorized. The following table presents a rollforward of changes in common shares issued and outstanding.

Years Ended December 31,
(in ones)
20242023
Issued and outstanding common shares, beginning of year13,131,672 13,422,692 
Issuance of common shares28,479 30,740 
Repurchase of common shares(370,034)(321,760)
Issued and outstanding common shares, end of year12,790,117 13,131,672 
Schedule Of Net Income Per Common Share
c) The following table presents net income (loss) per common share and diluted net income (loss) per common share.

Years Ended December 31,
(in thousands, except per share amounts)202420232022
Net income (loss) to common shareholders
$2,711,022 $1,960,060 $(252,277)
Adjustment of redeemable noncontrolling interests(111,700)6,212 (69,896)
Adjusted net income (loss) to common shareholders
$2,599,322 $1,966,272 $(322,173)
Weighted average basic common shares outstanding
13,017 13,347 13,580 
Weighted average dilutive potential common shares from restricted stock units and restricted stock (1) (2)
24 31 — 
Weighted average diluted common shares outstanding
13,041 13,378 13,580 
Basic net income (loss) per common share$199.69 $147.32 $(23.72)
Diluted net income (loss) per common share (1) (2)
$199.32 $146.98 $(23.72)
(1)    The Company has issued grants and awards of restricted stock units to employees as performance, retention or hiring incentives, as well as awards of restricted stock to non-employee directors, under its equity incentive compensation plan. At December 31, 2024, there were 284,049 shares available for future awards under the Company's equity incentive compensation plan.
(2)    The impact of 33 thousand shares from restricted stock units and restricted stock was excluded from the computation of diluted net loss per common share for the year ended December 31, 2022 because the effect would have been anti-dilutive.